Results 241 to 250 of about 231,821 (301)

Detection of a New Recombinant Rabbit Hemorrhagic Disease Virus 2 in China and Development of Virus-like Particle-Based Vaccine. [PDF]

Viruses
Hu B, Dong W, Song Y, Fan Z, Cavadini P, Wang F.   +5 more
europepmc   +1 more source

Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation. [PDF]

NPJ Vaccines
Sherry L, Grehan K, Bahar MW, Swanson JJ, Fox H, Matthews S, Carlyle S, Qin L, Porta C, Wilkinson S, Robb S, Clark N, Liddell J, Fry EE, Stuart DI, Macadam AJ, Rowlands DJ, Stonehouse NJ.   +17 more
europepmc   +1 more source

Simultaneous Packaging of Two Different RNA Segments into an Influenza C Virus-like Particle Occurs Inefficiently. [PDF]

Viruses
Muraki Y.
europepmc   +1 more source

A bacteriophage-based virus-like particle vaccine induces cross-reactive neutralising antibodies against porcine epidemic diarrhoea viruses (PEDV). [PDF]

Vet Res
Gu J, Zheng X, Li C, Wang S, Xie X, Bachmann MF, Nan Y, Li L, Sun P, Zha L, Chang X.   +10 more
europepmc   +1 more source

In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression. [PDF]

Cancer Immunol Immunother
Xu Y, Mcmillan A, Gupta N, Lemke-Miltner CD, Rataan AO, Areecheewakul S, Bhat DS, Lanzel EA, Geary SM, Simons AL, Weiner GJ, Salem AK.   +11 more
europepmc   +1 more source

Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanyl. [PDF]

NPJ Vaccines
Romano IG, Johnson-Weaver B, Core SB, Jamus AN, Brackeen M, Blough B, Dey S, Huang Y, Staats H, Wetsel WC, Chackerian B, Frietze KM.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hybrid Ty Virus-Like Particles

International Reviews of Immunology, 1994
Vaccines need to activate antigen presenting cells, overcome genetic restriction in T-cell responses and elicit both T and B memory cells. In order to produce recombinant vaccines which can do this, considerable effort has been put into developing particulate antigen presentation systems to generate polyvalent, high molecular weight antigens which ...
S E, Adams, N R, Burns, G T, Layton, A J, Kingsman   +3 more
openaire   +2 more sources

Virus-like particles as immunogens

Trends in Microbiology, 2003
Subunit vaccines based on recombinant proteins can suffer from poor immunogenicity owing to incorrect folding of the target protein or poor presentation to the immune system. Virus-like particles (VLPs) represent a specific class of subunit vaccine that mimic the structure of authentic virus particles.
Rob, Noad, Polly, Roy
openaire   +2 more sources

Virus-like particles in leukaemia

Experimental pathology, 1984
Hitherto intracytoplasmic virus-like particles have not been observed simultaneously in nucleus and cytoplasm in human lymphoblasts. We analysed 20 cases of lymphoblastic leukaemia in children and found some virus-like particles in cytoplasm (12 cases) and both in nucleus and cytoplasm (4 cases).
T, Slubowski, M, Kujawa
openaire   +2 more sources